Answer
Breastfeeding is contraindicated during thiotepa treatment because of its pharmacological properties and potential toxicity to breastfed newborns or infants, although whether thiotepa or its metabolites enter human milk is unknown.
Sources for this answer
- Thiotepa Riemser 15 mg powder for concentrate for solution for infusionEsteve Pharmaceuticals (formerly Intrapharm Laboratories) · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 2Document updated
Sources checked